Evidence map›Paper›PMID 21596100›Full record

ReviewBiochimica et biophysica acta2011

Isoprostanes and asthma.

Judith A Voynow, Apparao Kummarapurugu

Open access · greenAbstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. The association between prenatal FFree radical biology & medicine · 2022
    Article
  7. Leukotriene BHeliyon · 2021
    Article
  8. Article
  9. Article
  10. Features of Oxidative and Nitrosative Metabolism in Lung Diseases.Oxidative medicine and cellular longevity · 2019
    Review
  11. Article
  12. The Plant Proteinase InhibitorBioMed research international · 2018
    Article
  13. Article
  14. The isoprostanes--25 years later.Biochimica et biophysica acta · 2015
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Judith A VoynowDivision of Pediatric Pulmonary and Sleep Medicine, Duke University Medical Center, Durham, NC 27710, USA. judith.voynow@duke.edu
Apparao Kummarapurugu
Duke Medical Center · USDuke University · US

Funding

NQO1: Linking Oxidant Stress to Inflammation in Airway Epithelial CellsR01ES016836 · NIEHS · VIRGINIA COMMONWEALTH UNIVERSITY · PI VOYNOW, JUDITH A · 2010 to 2014
$1.7M
Mucin Gene Regulation by Elastase and OxidantsR01HL082504 · NHLBI · DUKE UNIVERSITY · PI VOYNOW, JUDITH A · 2005 to 2008
$1.2M
NHLBI NIH HHS HL082504NHLBI NIH HHS R01 HL082504NIEHS NIH HHS ES016836NIEHS NIH HHS R01 ES016836
6 · The paper itself

Abstract

Isoprostanes are prostaglandin (PG)-like compounds generated in vivo following oxidative stress by non-enzymatic peroxidation of polyunsaturated fatty acids, including arachidonic acid. They are named based on their prostane ring structure and by the localization of hydroxyl groups on the carbon side chain; these structural differences result in a broad array of isoprostane molecules with varying biological properties. Generation of specific isoprostanes is also regulated by host cell redox conditions; reducing conditions favor F₂-isoprostane production while under conditions with deficient antioxidant capacity, D₂- and E₂-isoprostanes are formed. F₂-isoprostanes (F₂-isoP) are considered reliable markers of oxidative stress in pulmonary diseases including asthma. Importantly, F₂-isoP and other isoprostanes function as ligands for PG receptors, and potentially other receptors that have not yet been identified. They have been reported to have important biological properties in many organs. In the lung, isoprostanes regulate cellular processes affecting airway smooth muscle tone, neural secretion, epithelial ion flux, endothelial cell adhesion and permeability, and macrophage adhesion and function. In this review, we will summarize the evidence that F₂-isoP functions as a marker of oxidative stress in asthma, and that F₂-isoP and other isoprostanes exert biological effects that contribute to the pathogenesis of asthma. This article is part of a Special Issue entitled Biochemistry of Asthma.

Indexed as

AnimalsAsthmaEpithelial CellsHumansIsoprostanesMuscle, SmoothOxidative StressIsoprostanes

Identifiers

PMID21596100
PMCPMC3192308
OpenAlexW1987899489

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.